Search research articles
Contact Us
Filters
Showing results (491-500 of 561) with videos related to
Page
of 57
Sort By:
American Heart Journal
|
October 11, 2011
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction
Thomas J Povsic, Christopher M O'Connor, Timothy Henry, et al.
The Lancet. Haematology
|
April 12, 2016
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Céline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.
BMC Pediatrics
|
April 18, 2015
Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States
Gloria S Pryhuber, Nathalie L Maitre, Roberta A Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2013
Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation
Farideh Miraki-Moud, Fernando Anjos-Afonso, Katharine A Hodby, et al.
Cell
|
February 7, 2012
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases
Sung-Jun Park, Faiyaz Ahmad, Andrew Philp, et al.
The Journal of Biological Chemistry
|
September 11, 2002
Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface
Marc Graille, Steven Harrison, Matthew P Crump, et al.
Blood
|
July 1, 2011
Differential and tumor-specific expression of CD160 in B-cell malignancies
Timothy W Farren, Jerome Giustiniani, Feng-Ting Liu, et al.
Signal Transduction and Targeted Therapy
|
February 27, 2023
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
Pedro Casado, Ana Rio-Machin, Juho J Miettinen, et al.
Plos One
|
May 5, 2009
HIV transmission in a state prison system, 1988-2005
Krishna Jafa, Peter McElroy, Lisa Fitzpatrick, et al.
Journal of Hematology & Oncology
|
November 14, 2025
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort
Jorge Cortes, Antonio Curti, Pierre Fenaux, et al.
Page
of 57
Search research articles
Search
Showing results (491-500 of 561) with videos related to
Sort By:
Page
of 57
American Heart Journal
|
October 11, 2011
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction
Thomas J Povsic, Christopher M O'Connor, Timothy Henry, et al.
The Lancet. Haematology
|
April 12, 2016
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Céline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.
BMC Pediatrics
|
April 18, 2015
Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States
Gloria S Pryhuber, Nathalie L Maitre, Roberta A Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2013
Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation
Farideh Miraki-Moud, Fernando Anjos-Afonso, Katharine A Hodby, et al.
Cell
|
February 7, 2012
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases
Sung-Jun Park, Faiyaz Ahmad, Andrew Philp, et al.
The Journal of Biological Chemistry
|
September 11, 2002
Evidence for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface
Marc Graille, Steven Harrison, Matthew P Crump, et al.
Blood
|
July 1, 2011
Differential and tumor-specific expression of CD160 in B-cell malignancies
Timothy W Farren, Jerome Giustiniani, Feng-Ting Liu, et al.
Signal Transduction and Targeted Therapy
|
February 27, 2023
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
Pedro Casado, Ana Rio-Machin, Juho J Miettinen, et al.
Plos One
|
May 5, 2009
HIV transmission in a state prison system, 1988-2005
Krishna Jafa, Peter McElroy, Lisa Fitzpatrick, et al.
Journal of Hematology & Oncology
|
November 14, 2025
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort
Jorge Cortes, Antonio Curti, Pierre Fenaux, et al.
Page
of 57